GO
Loading...

Celgene Corp

More

  • Your First Move For Thursday May 29th Wednesday, 28 May 2008 | 6:55 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Biotech’s Biggest Weekend Wednesday, 28 May 2008 | 6:27 PM ET

    With the ASCO conference beginning Friday new cancer drugs are likely to grab headlines. How should you trade ahead of biotech’s biggest weekend?

  • My recent post on the new Evista commercial from Eli Lilly elicited a few opinions including one from a woman who says she participated in a focus group for the spot. Laura Bliss says her comments at the time were that the "togas...made the women look like they were already sick....

  • Biotech's Big Night Thursday, 15 May 2008 | 6:38 PM ET

    Traders will be glued to the web Thursday night as thousands of cancer studies go online. What’s the trade as these studies potentially send shock waves through biotech stocks on Friday morning?

  • ASCO Countdown: Conference Season In Full Bloom Thursday, 15 May 2008 | 12:02 PM ET

    This is gonna be a crazy couple of days. At 9 pm ET tonight the American Society of Clinical Oncology is putting nearly 5,000 studies on its website all at once. Although ASCO says it's all about the science and protecting the "scientific integrity" of its upcoming conference, this is, frankly, an attempt to level the playing field for Wall Street.

  • 4-Star Biotech Stocks Wednesday, 14 May 2008 | 12:03 PM ET

    Will Muggia likes biotech. He's co-portfolio manager of the Touchstone Mid-Cap Growth Fund, which is up an average of 14.9 percent annually over the last three years -- and even this year, it's up 1.8 percent. So what are the 4-star portfolio manager's picks?

  • Cramer makes the call on viewers' favorite stocks.

  • Audience

    Occasionally -- when the bosses will let me -- I take a day to network, learn and maybe pick up a story idea by attending a biotech or healthcare investment conference. Many firms put on the events for their clients and they often invite reporters to hang out. ... The PR guy told me a couple of sessions during the day would be "closed" to me. It wasn't clear what the closed sessions were all about, and so my curiousity was piqued...

  • Market Insider/Thursday Look Ahead Wednesday, 7 May 2008 | 7:48 PM ET

    Retailers' April sales reports could shape early market action Thursday and provide a window on just how the consumer is faring.

  • Health Care Stocks with Healthy Outlooks Thursday, 24 Apr 2008 | 1:10 PM ET

    What's the best sector for improving your stock portfolio near-term?  Jeff Krumpleman of Fifth Third Asset Management thinks it's health care, and he has some specific selections that back him up.

  • Clank of America Monday, 21 Apr 2008 | 6:17 PM ET

    The Dow pulled back Monday after a weaker-than-expected profit report from Bank of America stirred concerns about the health of corporate earnings. What's the "Word on The Street?"

  • Happy Birthday CNBC - Markets Then and Now Thursday, 17 Apr 2008 | 9:24 AM ET

    Today, April 17, is CNBC's 19th birthday. Just look at how things have appreciated since then.

  • Month and Quarter End Winners and Losers Monday, 31 Mar 2008 | 4:53 PM ET

    Thank goodness Q1 is over!  Here's a summary of month-end and Q1 stats for stocks, commodities and currencies...

  • Lightning Round: Celgene, Apple, Chevron and More Tuesday, 25 Mar 2008 | 7:09 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • The Return of Big Pharma Friday, 14 Mar 2008 | 6:44 PM ET

    This could be the sector to own by next fall's presidential election.

  • Analyst: Pfizer Should Buy Amgen or Wyeth Friday, 7 Mar 2008 | 10:48 AM ET

    I thought I was finished with the post-Pfizer analyst meeting reaction with yesterday's post, but when an extraordinarily bearish 77-page research note from Credit Suisse big pharma analyst Catherine Arnold arrived in my inbox this morning, I had to do one more installment. She thinks Pfizer should buy Wyeth or Amgen...

  • Stocks Rebound; Oil Hits $104 Wednesday, 5 Mar 2008 | 9:18 PM ET

    The Dow snaps a losing streak as oil hits another all-time high. Get the news behind the headlines in the Word on the Street.

  • A Biotech Worth Buying? Wednesday, 6 Feb 2008 | 6:58 PM ET

    In Wednesday’s Web Extra, Pete Najarian reveals how he’s playing biotech. Could these stocks be just what the doctor ordered?

  • What the Pros Like: Where to Invest In This Market Wednesday, 6 Feb 2008 | 4:10 PM ET

    Stocks are having another up and down day.  So CNBC asked the experts where they would put their money in this kind of market.

  • Recession Nerves = Great Buying Opportunity Wednesday, 6 Feb 2008 | 3:01 PM ET

    David Spika, WHG Funds vice president, isn't afraid to use the "R" word -- but he's no bear.  He thinks the recession talk is overdone, making now a great time to buy stocks. He and Jeff Krumpelman of Fifth Third Asset Management offered CNBC their top picks.